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Abstract
Interventions to support adherence to antiretroviral therapy (ART) can be classified into four categories: cognitive, beha-
vioural and affective interventions and (modified) directly observed therapy (DOT.) 
Cognitive interventions improve HIV- and ART-related knowledge, but this is not consistently associated with better adhe-
rence. Cognitive interventions that are combined with behavioural or psychological strategies are more effective in improving 
adherence, especially in patients who previously were less adherent. These include interventions that improve self-efficacy, 
provide stress management/expressive support therapy or motivational interviewing. As yet there is no evidence for the role 
of affective interventions and modified DOT to improve adherence to ART. 
When designing interventions to address adherence, it should be borne in mind that multi-component interventions are more 
effective than single-focus interventions. A combination of educational, behavioural and affective components is suggested 
to ensure optimum adherence.
In countries with a high prevalence of HIV, such as South Africa, careful patient preparation, rather than selecting patients 
based on non-clinical predictors of adherence, seems an appropriate method for scaling up ART. South African guidelines 
focus on comprehensive adherence support to all patients, with additional support to patients with less than 80% adherence. 
More research on the effectiveness of interventions aimed at improving adherence is urgently needed, especially in develo-
ping countries.
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Introduction
Adherence to medication is probably 
the single biggest factor that needs 
to be addressed when planning an 
ART service. Patients need to take 
medication several times a day, ev-
ery day, for the rest of their lives. The 
South African National ART Guide-
lines state that ideal adherence 
means a patient must take more than 
95% of his or her doses (i.e. missing 
less than three doses in a month).1
The National ART Guidelines rec-
ommend the following strategies to 
promote adherence:
•  Spend time with the patient. Ex-
plain the goals of therapy and the 
need for adherence as many times 
as is necessary.
•  Consider the monitoring of medi-
cations such as co-trimoxazole, or 
by an alternative method prior to 
ART initiation.
•  Negotiate a treatment plan that 
the patient can understand and to 
which he/she commits.
•  Encourage disclosure to family or 
friends who can support the treat-
ment plan.
•  Inform the patient of potential side 
effects – severity, duration and 
coping mechanisms.
•  Establish ‘readiness’ to take medi-
cations before ART initiation.
•  Provide adherence tools where 
available: written calendar of medi-
cations, pill boxes.
•  Encourage use of alarms, pagers 
or other available mechanical re-
minder aids for adherence.
• Avoid adverse drug interactions. 
•  Anticipate, monitor and treat side 
effects.
•  Include adherence discussions in 
support groups.
•  Develop links with community-
based organisations.
•  Encourage links with support 
groups.
•  Create links with patient advo-
cates.1
Patients with adherence below 
80% require increased adherence 
support. Suggested interventions 
include: tablet counts to evaluate 
adherence and routine open-ended 
adherence discussions with the 
counsellor, allowing enough time 
for questions and the repetition of 
information; evaluating the support 
structures, including the home and 
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family environment; considering 
psychosocial profiling and participa-
tion in a support group or insisting 
on linking with a patient advocate; 
increasing home visits and consid-
ering directly-observed therapy for 
an agreed period; reassessing the 
patient for alcohol or drug use; us-
ing pillboxes, pill diaries and other 
adherence tools where possible; 
promoting self-efficacy training.1
Coetzee et al. state that care-
ful patient preparation, rather than 
selecting certain patients based 
on non-clinical predictors of adher-
ence, is a better-suited approach 
for scaling up ART in countries with 
large epidemics.2 In South Africa, the 
Khayelitsha/MSF programme devel-
oped a standard approach to patient 
preparation to enhance adherence. 
Patients attend three structured in-
dividual counselling sessions, iden-
tify a treatment assistant and attend 
peer support groups specifically for 
patients on ART. Material support, 
such as pillboxes, drug identifica-
tions charts, diaries and educational 
materials, are made available. A 
standard 12-week approach has 
been developed and applied with 
good results for patients who expe-
rience viral rebound.2
This review, the second in a two-part 
series, will evaluate interventions that 
have been designed to improve ad-
herence to ART. These interventions 
can be divided into four categories:
3,4
•  Cognitive (designed to teach, 
clarify or instruct) 
•  Behavioural (designed to shape, 
reinforce or influence behaviour)
•  Affective (designed to optimise 
social and emotional support) 




Cognitive interventions that common-
ly are used to improve adherence to 
ART include counselling sessions by 
healthcare workers and education 
sessions (providing information on 
ART, dosing instructions, drug inter-
actions, etc.). Several studies have 
described the use of an educational 
component in an attempt to improve 
adherence to ART.4,5,6,7,8 The results 
are variable, as most studies have 
shown an increase in knowledge 
of HIV and ART, but this was not 
consistently associated with bet-
ter adherence. Cognitive interven-
tions combined with behavioural 
or psychological strategies were 
more effective in improving adher-
ence.9,10,11,12 
Van Servellen et al. evaluated the 
acceptability and effectiveness of a 
programme to enhance health litera-
cy in low-income HIV-infected Latino 
men and women on ART. A signifi-
cant improvement in the participants’ 
knowledge regarding HIV/AIDS and 
their treatment-related knowledge 
was demonstrated in the intervention 
group, but there were no significant 
changes in adherence mastery and 
behaviour at the six-week follow-up 
visit. The participants rated the pro-
gramme highly on measures of satis-
faction, proving its acceptability.5
The impact of an educational inter-
vention on adherence was evaluated 
at six, twelve and eighteen months by 
Goujard et al.6 The intervention had 
an impact on adherence and knowl-
edge in the experimental group at 
six months, and this was maintained 
at 12 and 18 months. A delayed in-
crease in adherence was observed in 
the control group at 12 months. The 
intervention did not have a significant 
impact on quality of life and there was 
no significant difference in viral load 
and CD4 count.6 
Pradier et al. evaluated the impact 
of an educational and counselling 
intervention on ART adherence com-
pared to standard of care (SOC). 
The viral load decreased signifi-
cantly more in the intervention group 
(mean difference -0.22 log, p=0.013) 
than in the control group (+0.12 log, 
p=0.14). The proportion of patients 
that was adherent at six months was 
significantly better in the intervention 
group (75% vs. 61%, p=0.04).13 In 
an open label clinical trial, Rawl-
ings et al. evaluated the impact of 
an educational intervention plus 
routine counselling compared to 
routine counselling only.7 There was 
no significant difference between the 
groups with respect to the proportion 
of patients achieving viral load (VL) 
< 40 copies/ml (60 vs. 55%) or less 
than 400 copies/ml (80 vs. 80%) at 
24 weeks, the increase in median 
CD4 count (78.3 vs. 104.8) or the 
adherence rates as measured with 
MEMS (70 vs. 74%).7 
Fairley et al. offered a comprehen-
sive adherence package, including 
an education programme, individu-
alised planning of regimens and the 
opportunity for patients to choose 
from a number of adherence aids 
and reminder devices. The interven-
tion group self-reported a significant 
improvement in adherence during 
the previous four days (p=0.03) and 
seven days (p=0.005), but not for the 
previous 28 days (p=0.63).9
Jones et al. examined the effects of 
a ten-session cognitive-behavioural 
stress management/expressive sup-
port therapy intervention on adher-
ence. The intervention did not im-
prove adherence for the entire popu-
lation, but women with low adherence 
showed a significant increase post-in-
tervention (30.4% increase in adher-
ence) when compared to the control 
group (19.6% increase, p<0.01).10 
Accurate knowledge of HIV-related 
medication and a belief in the efficacy 
of the medication were consistently 
associated with higher levels of ad-
herence, highlighting the importance 
of assessing beliefs regarding medi-
cations. Women participating in the 
intervention decreased their levels of 
denial-based coping.10 
In a small pilot study (data for 33 
participants), Murphy et al. evalu-
ated the impact of a multi-component 
(cognitive-behavioural intervention 
and social support), multidisciplinary 
intervention on medication adher-
ence. Patients in the intervention 
group had significantly higher self-
efficacy to communicate with clinic 
staff (p=0.04), to continue treatment 
(p=0.04), and to use behavioural 
and cognitive strategies (p=0.01 
and 0.04). They reported higher life 
satisfaction (p=0.03) and increased 
feelings of social support (p=0.04). 
Although they did not significantly 
improve their adherence, the patients 
showed a trend towards taking their 
medication on time (p=0.06).11
The effect of a psycho-educative 
intervention on self-reported adher-
ence and HIV-1 RNA levels was 
evaluated by Tuldra et al.12 At week 
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48, 94% of the participants in the 
intervention group versus 69% of 
the participants in the control group 
achieved an adherence of ≥ 95% 
(p=0.008). The proportion of par-
ticipants with HIV-1 RNA level <400 
copies/ml was significantly higher in 
the intervention group (89% vs. 66%, 
p=0.026).12
A Cochrane Review of the lit-
erature identified one study that 
addressed interventions to improve 
adherence to ART. The study 
compared a pharmacist-led inter-
vention, consisting of educational 
counselling and the availability of 
follow-up telephone support, with the 
conventional dispensing of HAART 
pills. This intervention significantly 
improved adherence to highly active 
antiretroviral therapy (HAART), and 
adherence to HAART significantly 
predicted undetectable viral load at 
24 weeks. However, participating in 
the intervention did not significantly 
predict a subsequently undetectable 
viral load at 24 weeks.8 
Behavioural interventions
Behavioural interventions are de-
signed to shape, reinforce or influ-
ence beha-viour. Some suggested 
strategies that can be used to sup-
port adherence include giving the 
patient forms with pictures of the 
relevant pills and daily activities in 
order to communicate to the patient 
how many and when pills are to be 
taken, providing clearly written in-
structions, and questioning patients 
about their daily activities to identify 
regularly occurring events as trig-
gers for taking medication. Devices 
such as pill boxes and alarms may 
also be used.14
Other behavioural strategies 
that are employed to assist adher-
ence include cue-dose training 
with monetary reinforcement15 and 
the use of alarmed vials to remind 
patients to take their medication.16 
Two-way pagers have been used in 
uncontrolled trials.17 Psychological 
interventions described in one of the 
studies used self-management inter-
ventions to improve self-efficacy,18 
and in another study motivational 
interviewing was used.19
Rigsby et al. assessed the feasi-
bility and efficacy of an intervention 
using cue-dose training with and 
without monetary reinforcement ver-
sus standard care in a randomised 
controlled pilot study with three 
arms.15 MEMS pill bottle caps were 
used to measure adherence (open-
ing the bottle within two hours of a 
predetermined time). Adherence to 
taking medication was significantly 
enhanced during the four-week 
training period for the group that 
received cash reinforcements, while 
no significant improvement in com-
parison to the control group was 
observed in the group that received 
cue-dose training only. Eight weeks 
after training and reinforcements had 
been discontinued, adherence in the 
cash-reinforcement group returned 
to near baseline levels.15
Frick et al. conducted a study on 
the efficacy and acceptability of an 
alarm device to improve adherence 
among women in a resource-poor 
country.16 Women received a one-
month supply of multivitamins in an 
electronic medication vial with or 
without an alarm device. Although 
the study had several limitations 
(multivitamins cannot be com-
pared to the complexities of taking 
HAART,) women in the intervention 
arm were significantly more likely to 
have adherence levels of ≥95% (82% 
vs. 36%, p<0.001). Vial acceptability 
was high, with 99% of the women 
indicating that they would use the 
vial again.16 
One factor shown in past stud-
ies to be positively associated with 
antiretroviral adherence is self-ef-
ficacy. Self-efficacy is defined as 
one’s belief in one’s capability to 
organise and execute the course of 
action required to perform a particu-
lar activity. Bandura  proposed that 
self-efficacy is the most important 
prerequisite for behavioural change, 
because it affects how much effort 
is invested in a given task and what 
level of performance is attained. 20  
Individuals who regard themselves 
as highly self-efficacious in their abil-
ity to adhere will set higher goals, be 
more firmly committed to them and, 
therefore, exercise higher control 
over behaviour that fosters adher-
ence.18
According to social cognitive theory, 
information about the medication 
regimen is necessary, although not 
sufficient, to maintain adherence. 
Patients usually need guidance on 
how to cultivate self-regulatory and 
coping skills to translate information 
into action. An intervention to culti-
vate self-efficacy was evaluated by 
Smith et al.18 The three components 
of the intervention were self-monitor-
ing, goal setting and the enlistment 
of self-incentives. Individuals in the 
self-management group were sig-
nificantly more likely to take 80% or 
more of their doses each week than 
those in the control group (n=29, 
OR=7.8, 95% CI=2.2-28.1).18
Motivational interviewing (MI) 
was developed in the early 1980s 
as a therapy to promote behav-
ioural changes in individuals who 
were problem drinkers. Since then 
it has been applied to a variety of 
behaviours, including cessation of 
cigarette smoking, diabetes self-
management, fruit and vegetable in-
take and medication adherence. MI 
is a client-centred approach where 
counselling is tailored to the client’s 
needs and his or her readiness to 
change behaviour. In a non-judge-
mental, supportive environment, the 
clients describe their own situation, 
the reasons for and against change 
and ideas for resolving barriers for 
initiating change.19 In a small pilot 
study, trained nurse counsellors con-
ducted three motivational interview 
sessions with the clients. The study 
demonstrated a trend towards the 
sessions having a positive impact 
on adherence. This was more pro-
nounced in clients who had previous 
problems with adherence.19 
Comprehensive interventions 
combining cognitive and behavioural 
components and involving a multi-
disciplinary team result in better out-
comes than single approaches.21
Affective interventions
Affective interventions are designed 
to optimise social and emotional sup-
port for the patient. Affective strate-
gies formed part of multi-component 
interventions in two of the studies 
reviewed.10,11 However, the effective-
ness of affective interventions were 
not evaluated in these studies. 
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Directly observed therapy (DOT) or 
directly administered antiretroviral 
therapy (DAART)
Community-based DOT interventions 
have shown variable success. In a 
pilot study by Mitty et al., once-daily 
HAART was given to patients for five 
or seven days a week and gradu-
ally tapered according to patients’ 
needs. Only 13 out of 25 patients 
(56%) remained in the programme 
for longer than six months, and 63% 
of these individuals had viral loads 
less than 50 copies/ml.22 The experi-
ence in DOT programmes highlights 
the importance of participants un-
derstanding and having trust in the 
programme. The programme should 
be tailored according to the partici-
pants’ needs, but the intrusion and 
structure of the programme might 
lead to some patients withdrawing.22 
A more recent study by Mitty et al. 
supports the inclusion of a modi-
fied DOT (MDOT) in the spectrum 
of options available to enhance 
adherence to HAART among pa-
tients who are unsuccessful with the 
self-administration of their medica-
tions.23 The latter demonstrated a 
decrease of 2.7 log in the median 
baseline plasma viral load (RVL) af-
ter six months of MDOT.22 In general, 
patients experience DOT/DAART 
programmes positively and many 
patients develop a trusting relation-
ship with their community workers.24
The patients’ preferences should 
be taken into consideration when de-
ciding on a treatment regimen. Strong 
patient preferences for once-daily 
regimens seem to predominate.22 
The question remains whether all 
patients in a DOT programme should 
receive a once-daily observed dose 
or whether a twice-daily regimen, in 
which one dose is self-administered, 
is equally effective.22
Conclusions
Various interventions combining 
cognitive, behavioural, affective and 
modified DOT approaches have 
been studied to assess their impact 
on ART adherence. Several of these 
studies were small pilot studies, often 
of short duration, and thus did not 
have sufficient power to demonstrate 
a significant impact on adherence. 
Most of the cognitive interventions 
demonstrated a trend towards or sig-
nificant impact on adherence. The 
study included in the Cochrane Re-
view that evaluated a pharmacist-led 
intervention (educational counselling 
and follow-up telephone support) 
showed a significant improvement 
in adherence to HAART. However, 
knowledge about HIV and ART in 
itself is not always a sufficient force 
to motivate behavioural change. It is 
our suggestion that interventions that 
combine cognitive interventions with 
behavioural or affective strategies 
should be used when addressing 
ART adherence.
Interventions that improve self-ef-
ficacy, provide stress management/
expressive support therapy or in-
clude motivational interviewing all 
show very promising results. The 
impact of these interventions is of-
ten more pronounced in participants 
who previously had difficulties with 
adherence to medication. A belief in 
the efficacy of the medication was 
consistently associated with higher 
levels of adherence. This highlights 
the importance of assessing patient 
beliefs regarding medications. It is 
of particular relevance in the South 
African and African contexts, where 
Western medical beliefs may conflict 
with traditional beliefs.
There is yet no evidence for the 
role of DOT in improving ART adher-
ence. DOT might not be acceptable 
to all patients. If a DOT approach is 
utilised, the service should be tailored 
according to the patient’s needs. 
Questions that remain to be answered 
relate to the duration of DOT, the effi-
cacy of once-daily versus twice-daily 
regimens, and the identification of the 
key components of successful DOT 
programmes.
When designing interventions to 
address ART adherence, multi-com-
ponent interventions are more effec-
tive than single-focus interventions. 
A combination of educational, be-
havioural and affective components 
is suggested to ensure optimum 
adherence.
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